+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acute Respiratory Distress Syndrome (ARDS) - Epidemiology Forecast - 2030

  • ID: 4330800
  • Report
  • July 2020
  • Region: Global
  • 100 pages
  • DelveInsight

‘Acute Respiratory Distress Syndrome (ARDS) - Epidemiology Forecast-2030' report delivers an in-depth understanding of the disease, historical and forecasted Acute Respiratory Distress Syndrome (ARDS) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

Acute Respiratory Distress Syndrome (ARDS) Understanding

Acute respiratory distress syndrome (ARDS) is a rapidly progressive disease occurring in critically ill patients. The main complication in ARDS is that fluid leaks into the lungs, making breathing difficult or impossible. Acute lung injury (ALI) is a common condition characterized by acute severe hypoxia that is not due to left atrial hypertension. The term ALI encompasses a continuum of clinical and radiographic changes that affect the lungs with the acute respiratory distress syndrome (ARDS) representing the more severe end of this continuum. Despite advances in the understanding of the pathophysiology and management of ALI, it is still associated with high mortality.

The causes of ARDS are divided into two categories: direct or indirect injuries to the lung. Some of the direct injuries to the lung include pneumonia, aspiration, trauma, and others whereas the indirect injuries to the lung include inflammation of the pancreas, severe infection (also known as sepsis), blood transfusions, burns, and medication reactions. The few symptoms of ARDS are shortness of breath, cough, and fever. In some cases, those with ARDS also have fast heart rates and rapid breathing. Occasionally, patients of ARDS experience chest pain, especially during inhalation. Some patients also experience bluish coloring of nails and lips due to the severely decreased oxygen levels in the blood. There are several risks factors that may escalate the risk for ARDS; this involves obesity, alcohol abuse, chemotherapy, low-protein in blood.

Acute Respiratory Distress Syndrome (ARDS) Epidemiology Perspective

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Incident Population of ARDS, Severity-specific Incidence of ARDS and Incidence of ARDS by Risk Factors scenario of Acute Respiratory Distress Syndrome (ARDS) in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan from 2017 to 2030.

Acute Respiratory Distress Syndrome (ARDS) Detailed Epidemiology Segmentation

  • In the 7MM, the total incident population of ARDS is estimated to be 7,99,872 in 2017.
  • Generally, the highest number of incident cases were assessed for ARDS due to pneumonia, in all the 7MM countries, except the United Kingdom, in which sepsis was the primary risk factor for ARDS.
  • The estimates show a higher incidence of ARDS in the United States with 4, 95,655 cases in 2017.

Scope of the Report

  • The report covers the descriptive overview of Acute Respiratory Distress Syndrome (ARDS), explaining its causes, signs and symptoms, pathophysiology and currently available therapies.
  • The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of Acute Respiratory Distress Syndrome (ARDS).
  • The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of Acute Respiratory Distress Syndrome (ARDS), Total Diagnosed and Treated Cases of Acute Respiratory Distress Syndrome (ARDS).

Report Highlights

  • Eleven-Year Forecast of Acute Respiratory Distress Syndrome (ARDS)
  • 7MM Coverage
  • Total Incident Population of ARDS
  • Severity-specific Incidence of ARDS
  • Incidence of ARDS by Risk Factors
  • Total Incident Population of Acute Respiratory Distress Syndrome (ARDS) in the 7MM is estimated to increase at a CAGR of 1.07%
  • Severity-specific Incident Population of Acute Respiratory Distress Syndrome (ARDS) in the 7MM is projected to rise at a CAGR of 0.92%.

Key Questions Answered

  • What is the disease risk, burden and unmet needs of Acute Respiratory Distress Syndrome (ARDS)?
  • What is the historical Acute Respiratory Distress Syndrome (ARDS) patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?
  • What would be the forecasted patient pool of Acute Respiratory Distress Syndrome (ARDS) at the 7MM level?
  • What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Acute Respiratory Distress Syndrome (ARDS)?
  • Out of the countries mentioned above, which country would have the highest prevalent population of Acute Respiratory Distress Syndrome (ARDS) during the forecast period (2020-2030)?
  • At what CAGR the population is expected to grow across the 7MM during the forecast period (2020-2030)? 

Reasons to Buy

The Acute Respiratory Distress Syndrome (ARDS) report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the 7MM Acute Respiratory Distress Syndrome (ARDS) market.
  • Quantify patient populations in the 7MM Acute Respiratory Distress Syndrome (ARDS) market to improve product design, pricing, and launch plans.
  • The Acute Respiratory Distress Syndrome (ARDS) epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
  • The Acute Respiratory Distress Syndrome (ARDS) epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Note: Product cover images may vary from those shown
1 Key Insights

2 Executive Summary

3 SWOT Analysis

4 Acute Respiratory Distress Syndrome (ARDS): Epidemiology Overview at a Glance
4.1 Total Epidemiology Share (%) Distribution of ARDS in 2017
4.2 Total Epidemiology Share (%) Distribution of ARDS in 2030

5 Acute Respiratory Distress Syndrome (ARDS): Disease Background and Overview
5.1 Introduction
5.1.1 Consensus Definitions of Acute Lung Injury and Acute Respiratory Distress Syndrome (ARDS)
5.1.2 Development of Berlin Definition of ARDS
5.1.3 Problems with the AECC definition and subsequent Berlin definition of acute respiratory distress syndrome (ARDS)
5.2 Causes and Risk Factors
5.2.1 Risk Factors of Acute Respiratory Distress Syndrome (ARDS)
5.3 Pathophysiology of Acute Respiratory Distress Syndrome (ARDS)
5.3.1 Inflammatory Processes in ARDS
5.3.2 The initial event of injury
5.3.3 Endothelial Damage
5.3.4 Specific Mediators of Inflammation and Lung Damage in ARDS
5.3.5 Altered Pulmonary Physiology in ARDS
5.3.6 Genetics
5.4 Stages of Acute Respiratory Distress Syndrome (ARDS)
5.5 Ventilator-Induced Lung Injury (VILI)
5.6 Major Determinants of VILI
5.6.1 Ventilator determinants of VILI
5.6.2 Patient determinants of VILI
5.7 Diagnosis of Acute Respiratory Distress Syndrome (ARDS)
5.7.1 Imaging techniques in ARDS
5.7.2 Imaging findings in ARDS
5.7.3 Differential Diagnosis

6 Recognized Establishments

7 Epidemiology and Patient Population
7.1 Key Findings
7.2 Methodology

8 7MM Epidemiology Analysis
8.1 Total Incident Population of Acute Respiratory Distress Syndrome (ARDS) in the 7MM
8.2 Severity-specific Incident Population of Acute Respiratory Distress Syndrome (ARDS) in the 7MM

9 United States Epidemiology
9.1 Assumptions and Rationale
9.2 Total Incident Population of Acute Respiratory Distress Syndrome (ARDS) in the United States
9.3 Severity-specific Incident Population of ARDS in the United States
9.4 Incident Population of ARDS by Risk Factors in the United States

10 EU5 Epidemiology
10.1 Germany Epidemiology
10.1.1 Assumptions and Rationale
10.1.2 Total Incident Population of Acute Respiratory Distress Syndrome (ARDS) in Germany
10.1.3 Severity-specific Incidence of ARDS in Germany
10.1.4 Incident Population of ARDS by Risk Factors in Germany
10.2 France Epidemiology
10.2.1 Assumptions and Rationale
10.2.2 Total Incident Population of Acute Respiratory Distress Syndrome (ARDS), in France
10.2.3 Severity-specific Incidence of ARDS in France
10.2.4 Incident Population of ARDS by Risk Factors in France
10.3 Italy Epidemiology
10.3.1 Assumptions and Rationale
10.3.2 Total Incident Population of Acute Respiratory Distress Syndrome (ARDS) in Italy
10.3.3 Severity-specific Incidence of ARDS in Italy
10.3.4 Incident Population of ARDS by Risk Factors in Italy
10.4 Spain Epidemiology
10.4.1 Assumptions and Rationale
10.4.2 Total Incident Population of Acute Respiratory Distress Syndrome (ARDS) in Spain
10.4.3 Severity-specific Incidence of ARDS in Spain
10.4.4 Incident Population of ARDS by Risk Factors in Spain
10.5 United Kingdom Epidemiology
10.5.1 Assumptions and Rationale
10.5.2 Total Incident Population of Acute Respiratory Distress Syndrome (ARDS) in the United Kingdom
10.5.3 Severity-specific Incidence of ARDS in the United Kingdom
10.5.4 Incident Population of ARDS by Risk Factors in the United Kingdom

11 Japan Epidemiology
11.1 Assumptions and Rationale
11.2 Total Incident Population of Acute Respiratory Distress Syndrome (ARDS), ARDS in Japan
11.3 Severity-specific Incidence of ARDS in Japan
11.4 Incident Population of ARDS by Risk Factors in Japan

List of Tables
Table 1: Definition of Acute Respiratory Distress Syndrome (ARDS)
Table 2: American European Consensus Conference Criteria for Acute Lung Injury (ALI) and the Acute Respiratory Distress Syndrome (ARDS)
Table 3: Berlin Definition of Mild, Moderate, and Severe Acute Respiratory Distress Syndrome (ARDS)
Table 4: Factors That Distinguish ARDS, CHF, and Pneumonia
Table 5: Total Incident Population of ARDS in the 7MM (2017-2030)
Table 6: Severity-specific Incident Population of ARDS in the 7MM (2017-2030)
Table 7: Total Incident Population of ARDS in the US (2017-2030)
Table 8: Severity-specific Incident Population of ARDS in the US (2017-2030)
Table 9: Incidence of ARDS by Risk Factors in the US (2017-2030)
Table 10: Total Incident Population of ARDS in Germany (2017-2030)
Table 11: Severity-specific Incident Population of ARDS in Germany (2017-2030)
Table 12: Incidence of ARDS by Risk Factors in Germany (2017-2030)
Table 13: Total Incident Population of ARDS in France (2017-2030)
Table 14: Severity-specific Incident Population of ARDS in France (2017-2030)
Table 15: Incidence of ARDS by Risk Factors in France (2017-2030)
Table 16: Total Incident Population of ARDS in Italy (2017-2030)
Table 17: Severity-specific Incident Population of ARDS in Italy (2017-2030)
Table 18: Incidence of ARDS by Risk Factors in Italy (2017-2030)
Table 19: Total Incident Population of ARDS in Spain (2017-2030)
Table 20: Severity-specific Incident Population of ARDS in Spain (2017-2030)
Table 21: Incidence of ARDS by Risk Factors in Spain (2017-2030)
Table 22: Total Incident Population of ARDS in the UK (2017-2030)
Table 23: Severity-specific Incident Population of ARDS in the UK (2017-2030)
Table 24: Incidence of ARDS by Risk Factors in the UK (2017-2030)
Table 25: Total Incident Population of ARDS in Japan (2017-2030)
Table 26: Severity-specific Incident Population of ARDS in Japan(2017-2030)
Table 27: Incidence of ARDS by Risk Factors in Japan (2017-2030)

List of Figures
Figure 1: Acute Respiratory Distress Syndrome (ARDS) SWOT Analysis
Figure 2: Common Symptoms of Acute Respiratory Distress Syndrome (ARDS)
Figure 3: Risk Factors of Acute Respiratory Distress Syndrome (ARDS)
Figure 4: Pathophysiology of ABPA
Figure 5: Proposed Algorithm for the Diagnosis of CPA
Figure 6: Algorithm for the Diagnosis of ABPA in Asthma
Figure 7: Acute Respiratory Distress Syndrome (ARDS) Prevalent Cases in the 7MM Countries (2017-2030)
Figure 8: Acute Respiratory Distress Syndrome (ARDS) Diagnosed and treated pool by types in the 7MM Countries (2017-2030)
Figure 9: Acute Respiratory Distress Syndrome (ARDS) Prevalent Cases in the United States (2017-2030)
Figure 10: Acute Respiratory Distress Syndrome (ARDS) Diagnosed and treated pool by types in the United States (2017-2030)
Figure 11: Acute Respiratory Distress Syndrome (ARDS) Prevalent Cases in Germany (2017-2030)
Figure 12: Acute Respiratory Distress Syndrome (ARDS) Diagnosed and treated pool by types in Germany (2017-2030)
Figure 13: Acute Respiratory Distress Syndrome (ARDS) Prevalent Cases in France (2017-2030)
Figure 14: Acute Respiratory Distress Syndrome (ARDS) Diagnosed and treated pool by types in France (2017-2030)
Figure 15: Acute Respiratory Distress Syndrome (ARDS) Prevalent Cases in Italy (2017-2030)
Figure 16: Acute Respiratory Distress Syndrome (ARDS) Diagnosed and treated pool by types in Italy (2017-2030)
Figure 17: Acute Respiratory Distress Syndrome (ARDS) Prevalent Cases in Spain (2017-2030)
Figure 18: Acute Respiratory Distress Syndrome (ARDS) Diagnosed and treated pool by types in Spain (2017-2030)
Figure 19: Acute Respiratory Distress Syndrome (ARDS) Prevalent Cases in the UK (2017-2030)
Figure 20: Acute Respiratory Distress Syndrome (ARDS) Diagnosed and treated pool by type in the UK (2017-2030)
Figure 21: Acute Respiratory Distress Syndrome (ARDS) Prevalent Cases in Japan (2017-2030)
Figure 22: Acute Respiratory Distress Syndrome (ARDS) Diagnosed and treated pool by types in Japan (2017-2030)
Note: Product cover images may vary from those shown
Adroll
adroll